CommercialAdministrativeLow impact
11.08.17k, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toenails
Independence Blue Cross·PA · Podiatry, Dermatology, General Surgery·Medical Policy
We identified it
Jun 19, 2026
Summary
Independence Blue Cross reissued policy 11.08.17l on 04/02/2025, communicating the company's continuing position on debridement of mycotic and symptomatic non-mycotic hypertrophic toenails. No substantive coverage criteria changes were made; this is a routine policy reissuance. Billing teams should verify they are using version 11.08.17l (the current version) rather than superseded version 11.08.17k, as the older version has been removed from the IBX portal.
Action Required
Verify that billing software and claim submission workflows reference policy version 11.08.17l (not superseded version 11.08.17k). No changes to medical necessity criteria, billing codes, or coverage rules are required. Providers should continue to apply the existing coverage criteria for toenail debridement (CPT 11720, 11721) with appropriate ICD-10 diagnosis codes. No immediate action is required unless your system still references the outdated version.